The effect of Vitamin D on early-life wheezing after RS virus infection: A randomized, double-blinded placebo-controlled study

The effect of Vitamin D on early-life wheezing after RS virus infection: A randomized, double-blinded placebo-controlled study - The effect of Vitamin D on early-life wheezing after RS virus infection: A randomized, double-blinded placebo-controlled study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033600

Enrollment

150

Registered

2018-08-02

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RS virus infection

Interventions

Vitamin D Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are administered for RS virus infection

Exclusion criteria

Exclusion criteria: Patients who are already taking Vitamin D Patients who thought to require advanced airway management on administration

Design outcomes

Primary

Measure	Time frame
Number of wheezing for 12 months after entry.	—

Secondary

Measure	Time frame
Duration of administration Duration of oxygen supply	—

Countries

Japan

Contacts

Public ContactKyohei Takahashi

National Sagamihara Hospital Department of Pediatrics

kcrt@kcrt.net042-742-8311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026